Kiadis Pharma N.V.’s €18 million private placement of new shares

Ashurst advised Jefferies, as sole bookrunner, in relation to an accelerated book build private placement of new shares by Kiadis Pharma N.V., a clinical stage biopharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now